InvestorsHub Logo
Followers 24
Posts 1682
Boards Moderated 0
Alias Born 06/05/2009

Re: Wangenstein post# 76521

Wednesday, 03/14/2018 4:21:29 PM

Wednesday, March 14, 2018 4:21:29 PM

Post# of 196259
What about their margins, seems pretty steep to me:
2016 Total Revenue: $18,318,567
2016 net income: $209,319

That's about a 2016 EPS of .00056 at let's say today's share price of .17 per share price that's X30,357 forward earnings...

To say "RXMD isn't going anywhere but up" is simply ludicrous.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.